Imagion Biosystems Limited (ASX:IBX)
0.0080
0.00 (0.00%)
Sep 7, 2026, 9:59 AM AEST
Imagion Biosystems Revenue
Imagion Biosystems had revenue of 525.93K AUD in the half year ending June 30, 2026, a decrease of -67.83%. This brings the company's revenue in the last twelve months to 573.23K, down -45.71% year-over-year. In the year 2025, Imagion Biosystems had annual revenue of 73.03K, down -97.26%.
Revenue (ttm)
573.23K
Revenue Growth
-45.71%
P/S Ratio
7.54
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.32M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 73.03K | -2.59M | -97.26% |
| Dec 31, 2024 | 2.67M | -2.31M | -46.38% |
| Dec 31, 2023 | 4.97M | 1.90M | 61.87% |
| Dec 31, 2022 | 3.07M | 215.36K | 7.54% |
| Dec 31, 2021 | 2.86M | 158.60K | 5.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Healius | 1.37B |
| Australian Clinical Labs | 736.15M |
| Monash IVF Group | 269.46M |
| ImExHS | 31.27M |
| Genetic Signatures | 19.33M |
| Cryosite | 16.70M |
| Microba Life Sciences | 14.76M |
| BCAL Diagnostics | 2.35M |
Imagion Biosystems News
- 7 months ago - Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent - Business Wire